The MedicX Fund Limited Scrip Dividend Declaration (7645H)
March 14 2018 - 1:58PM
UK Regulatory
TIDMMXF
RNS Number : 7645H
The MedicX Fund Limited
14 March 2018
For immediate release
14 March 2018
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Scrip Dividend Declaration
MedicX Fund (LSE: MXF) announces that, pursuant to its scrip
dividend scheme (the "Scrip Dividend Alternative"), elections were
received in respect of 2.1 per cent. of the ordinary shares in
issue as at the record date of 16 February 2018. Electing
shareholders will receive ordinary shares of no par value in the
Company ("Shares") in lieu of receiving cash for the March 2018
dividend in respect of the quarter ended 31 December 2017.
Accordingly, 147,245 Shares will be sold out of treasury by the
Company on 29 March 2018 to shareholders who elected to participate
in the Scrip Dividend Alternative.
The Shares will rank pari passu with the existing ordinary
shares.
Following the transaction, the Company is expected to have
436,002,399 ordinary shares in issue, of which 7,021,823 will be
held in treasury. Accordingly the total voting rights in issue are
expected to be 428,980,576 in the absence of any further
transactions in the Company's ordinary shares before 29 March
2018.
In addition the Company has 14,771,668 ordinary shares of no par
value remaining under its block listing facility.
Copies of the documents relating to the Scrip Dividend
Alternative are available for inspection through the National
Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).
End
For further information please contact:
Octopus Healthcare Adviser Limited +44 (0) 345 0404 5555
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited (the "Fund" or the "Company", or together
with its subsidiaries, the "Group") is the specialist primary care
infrastructure investor in modern, purpose-built primary healthcare
properties in the United Kingdom and Ireland, listed on the London
Stock Exchange, with a portfolio comprising 153 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1.2 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP7 billion of funds for more than 50,000 retail and institutional
investors as well as supplying energy to more than 100,000
customers
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25
This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVDZLFFVXFEBBL
(END) Dow Jones Newswires
March 14, 2018 13:58 ET (17:58 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024